Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Foghorn Therapeutics (FHTX) Change in Acquisitions & Divestments: 2021-2025

Historic Change in Acquisitions & Divestments for Foghorn Therapeutics (FHTX) over the last 5 years, with Sep 2025 value amounting to $39.6 million.

  • Foghorn Therapeutics' Change in Acquisitions & Divestments fell 37.63% to $39.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $258.5 million, marking a year-over-year increase of 20.64%. This contributed to the annual value of $232.5 million for FY2024, which is 5.87% up from last year.
  • According to the latest figures from Q3 2025, Foghorn Therapeutics' Change in Acquisitions & Divestments is $39.6 million, which was down 47.92% from $76.0 million recorded in Q2 2025.
  • Foghorn Therapeutics' 5-year Change in Acquisitions & Divestments high stood at $94.5 million for Q2 2021, and its period low was $19.0 million during Q2 2022.
  • Its 3-year average for Change in Acquisitions & Divestments is $58.9 million, with a median of $58.5 million in 2024.
  • Per our database at Business Quant, Foghorn Therapeutics' Change in Acquisitions & Divestments plummeted by 79.89% in 2022 and then skyrocketed by 303.02% in 2023.
  • Foghorn Therapeutics' Change in Acquisitions & Divestments (Quarterly) stood at $20.0 million in 2021, then skyrocketed by 90.50% to $38.1 million in 2022, then grew by 16.17% to $44.3 million in 2023, then soared by 41.02% to $62.4 million in 2024, then crashed by 37.63% to $39.6 million in 2025.
  • Its last three reported values are $39.6 million in Q3 2025, $76.0 million for Q2 2025, and $80.6 million during Q1 2025.